Literature DB >> 10225225

Detection and enumeration of HIV-1-producing cells by ELISPOT (enzyme-linked immunospot) assay.

P Corne1, M F Huguet, L Briant, M Segondy, J Reynes, J P Vendrell.   

Abstract

The enzyme-linked immunospot (ELISPOT) assay was adapted to detect and enumerate HIV-1-producing cells at the single cell level. With CEM cells or peripheral blood mononuclear cells (PBMC) infected in vitro with HIV-1, the ELISPOT assay detected cells that produced HIV-1 antigens and showed that between 5.4% and 9.5% of the p24 antigen-positive CEM cells and 11.1% to 23.6% of the p24 antigen-positive PBMC were productively infected. In HIV-1-infected patients in early stage of the disease and without antiretroviral therapy, up to 4.54 HIV-1-producing cells per 10(6) CD4+ T lymphocytes were detected in peripheral blood and up to 277.75 HIV-1-producing cells per 10(6) CD4+ T lymphocytes were detected in splenic lymphoid tissue. Our results indicate that the ELISPOT assay could represent a new tool to study HIV-1 replication in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225225     DOI: 10.1097/00042560-199904150-00005

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  2 in total

1.  Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals.

Authors:  Jean-Michel Fondere; Gael Petitjean; Marie-France Huguet; Sharon Lynn Salhi; Vincent Baillat; Anna Macura-Biegun; Pierre Becquart; Jacques Reynes; Jean-Pierre Vendrell; Anna Macura-Biegum
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

2.  VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.

Authors:  Maria C Puertas; Ángel Bayón-Gil; Maria C Garcia-Guerrero; Maria Salgado; Víctor Urrea; Sara Morón-López; Ruth Peña; Esther Jiménez-Moyano; Bonaventura Clotet; Julia G Prado; Javier Martinez-Picado
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.